Diego
Serrano Tejero
Colaborador Docente
Publikationen (24) Publikationen von Diego Serrano Tejero
2023
-
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
Cancers, Vol. 15, Núm. 12
-
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526
-
Presence of Activated (Phosphorylated) STAT3 in Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases
International Journal of Molecular Sciences, Vol. 24, Núm. 18
2022
-
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
Biomedicines, Vol. 10, Núm. 7
-
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 8
-
Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma
DMM Disease Models and Mechanisms, Vol. 15, Núm. 1
-
YES1 Is a Druggable Oncogenic Target in SCLC
Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1387-1403
2021
-
Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies
Cancers, Vol. 13, Núm. 12
-
Challenges and novel opportunities of radiation therapy for brain metastases in non-small cell lung cancer
Cancers, Vol. 13, Núm. 9
-
Circulating levels of the interferon-γ-regulated chemokines cxcl10/cxcl11, il-6 and hgf predict outcome in metastatic renal cell carcinoma patients treated with antiangiogenic therapy
Cancers, Vol. 13, Núm. 11
-
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 9
-
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3
2020
-
Drugsniper, a tool to exploit loss-of-function screens, identifies CREBBP as a predictive biomarker of VOLASERTIB in small cell lung carcinoma (SCLC)
Cancers, Vol. 12, Núm. 7, pp. 1-18
-
Repeated stereotactic radiosurgery for recurrent brain metastases: An effective strategy to control intracranial oligometastatic disease
Critical Reviews in Oncology/Hematology, Vol. 153
-
The Smc5/6 Core Complex Is a Structure-Specific DNA Binding and Compacting Machine
Molecular Cell, Vol. 80, Núm. 6, pp. 1025-1038.e5
2016
-
Centrosome-Dependent Bypass of the DNA Damage Checkpoint by the Polo Kinase Cdc5
Cell Reports, Vol. 14, Núm. 6, pp. 1422-1434
-
Checkpoint adaptation: Keeping Cdc5 in the T-loop
Cell Cycle
2014
-
When genome integrity and cell cycle decisions collide: roles of polo kinases in cellular adaptation to DNA damage
Systems and Synthetic Biology, Vol. 8, Núm. 3, pp. 195-203
2013
-
Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFΒ1-targeting peptides P17 and P144
Experimental Cell Research, Vol. 319, Núm. 3, pp. 12-22
-
Multiscale in situ analysis of the role of dyskerin in lung cancer cells
Integrative Biology (United Kingdom), Vol. 5, Núm. 2, pp. 402-413